相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protective CD8+T lymphocytes in Primates Immunized with Malaria Sporozoites
Walter R. Weiss et al.
PLOS ONE (2012)
Baculovirus as a vaccine vector
Hsin-Yu Lu et al.
BIOENGINEERED (2012)
Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications
Chi-Yuan Chen et al.
BIOTECHNOLOGY ADVANCES (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vaccine Platforms Combining Circumsporozoite Protein and Potent Immune Modulators, rEA or EAT-2, Paradoxically Result in Opposing Immune Responses
Nathaniel J. Schuldt et al.
PLOS ONE (2011)
Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
Cindy Tamminga et al.
PLOS ONE (2011)
Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice
Christopher Palma et al.
VACCINE (2011)
The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
Katarina Radosevic et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Host Innate Immune Responses Induced by Baculovirus in Mammals
Takayuki Abe et al.
CURRENT GENE THERAPY (2010)
Baculovirus-Based Nasal Drop Vaccine Confers Complete Protection against Malaria by Natural Boosting of Vaccine-Induced Antibodies in Mice
Shigeto Yoshida et al.
INFECTION AND IMMUNITY (2010)
Advances and challenges in malaria vaccine development
Peter D. Crompton et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Plasmodium berghei Circumvents Immune Responses Induced by Merozoite Surface Protein 1-and Apical Membrane Antigen 1-Based Vaccines
Shigeto Yoshida et al.
PLOS ONE (2010)
A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates
Joanna Kubler-Kielb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission
Andrew M. Blagborough et al.
VACCINE (2010)
Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen
Godfree Mlambo et al.
VACCINE (2010)
A Baculovirus Dual Expression System-Based Malaria Vaccine Induces Strong Protection against Plasmodium berghei Sporozoite Challenge in Mice
Shigeto Yoshida et al.
INFECTION AND IMMUNITY (2009)
Baculovirus Induces Type I Interferon Production through Toll-Like Receptor-Dependent and -Independent Pathways in a Cell-Type-Specific Manner
Takayuki Abe et al.
JOURNAL OF VIROLOGY (2009)
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
Vasee S. Moorthy et al.
MALARIA JOURNAL (2009)
Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
Caterina Guinovart et al.
PLOS ONE (2009)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
TRENDS IN IMMUNOLOGY (2009)
Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys
S. Pichyangkul et al.
VACCINE (2009)
Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori
Rongzhong Jin et al.
PLOS ONE (2008)
Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito
Shigeto Yoshida et al.
BLOOD (2008)
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique:: a double blind randomised controlled phase I/IIb trial
John J. Aponte et al.
LANCET (2007)
Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein
Robert Strauss et al.
MOLECULAR THERAPY (2007)
A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
S. J. Dunachie et al.
INFECTION AND IMMUNITY (2006)
Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes
DL Medica et al.
INFECTION AND IMMUNITY (2005)
Targeting the innate immune response with improved vaccine adjuvants
A Pashine et al.
NATURE MEDICINE (2005)
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria
ES Bergmann-Leitner et al.
INTERNATIONAL IMMUNOLOGY (2005)
The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion
A Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
分享论文
